High cholesterol in COVID-19 leading to lung consolidation and bronchiectasis

Tasneem Sajjad Burhani, Waqar Mohsin Naqvi

PAMJ. 2021; 39:115. Published 09 Jun 2021 | doi:10.11604/pamj.2021.39.115.29961

A 60-years-old male with high cholesterol and a Modified Medical Research Council (mMRC) dyspnoea score of 2 was admitted with a history of fever, cough, dyspnoea. Initial chest radiograph (A) showed bronchiectasis in right base with pneumonia in the left base. A diagnosis of COVID-19 was confirmed with positive SARS-CoV-2 RT-PCR on nasal swab. There were some typical findings on CT images. According to the CT images (B), the case was classified as of stage I consolidation with multiple peripheral ground glass opacities with interlobular septal thickening were seen in anterior and inferior lingular segment of left upper lobe, posterior basal segment of left lower lobe, posterior segment of right upper lobe, and medial segment of right middle lobe. Initially he was on IV steroids and therapeutic doses of heparin. He was maintaining his oxygen saturation to 96%. Ten (10) days after hospitalization and normalization of all inflammatory markers, he has Modified Medical Research Council (mMRC) dyspnoea score 1 and oxygen-independent. The patient was asked for follow up in 6 weeks. Due to the mMRC of 1 and short history, it is assumed that the fibrosis was not present prior to the COVID-19 diagnosis. The early use of antifibrotics may prevent this devastating complication, but it is difficult to predict who is likely to progress to pulmonary fibrosis. Early rehabilitation protocol for post-acute COVID-19 patients can minimize dyspnea and shortness of breath even for minimal activities.
Corresponding author
Waqar Mohsin Naqvi, Department of Community Health Physiotherapy, Ravi Nair Physiotherapy College, Wardha, Maharashtra, India (waqar.naqvi@dmimsu.edu.in)

The Pan African Medical Journal (ISSN: 1937-8688) is a subsidiary of the Pan African Medical Journal. The contents of this journal is intended exclusively for professionals in the medical, paramedical and public health and other health sectors.

Currently tracked by: DOAJ, AIM, Google Scholar, AJOL, EBSCO, Scopus, Embase, IC, HINARI, Global Health, PubMed Central, PubMed/Medline, ESCI

Physical address: Kenya: 3rd Floor, Park Suite Building, Parkland Road, Nairobi. PoBox 38583-00100, tel: +254 (0)20-520-4356 | Cameroon: Immeuble TechnoPark Essos, Yaounde, PoBox: 10020 Yaounde, tel: +237 (0)24-309-5880